The role of purinergic receptors in cancer-induced bone pain

Journal of Osteoporosis

Volumn 2012, Issue , 2012, Pages

  Falk, Sarah ^a   Uldall, Maria ^a   Heegaard, Anne Marie ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; ADENOSINE TRIPHOSPHATE; AF 353; ANALGESIC AGENT; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG;

BONE PAIN; CARCINOGENESIS; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NERVE CELL; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

EID: 84876509445     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2012/758181     Document Type: Review

References (122)

1. Delaney A., Fleetwood-Walker S. M., Colvin L. A., Fallon M., Translational medicine: cancer pain mechanisms and management. British Journal of Anaesthesia 2008 101 1 87 94 2-s2.0-45849109115 10.1093/bja/aen100 (Pubitemid 351881906)
2. Urch C., The pathophysiology of cancer-induced bone pain: Current understanding. Palliative Medicine 2004 18 4 267 274 2-s2.0-2942685488 10.1191/0269216304pm887ra (Pubitemid 38771669)
3. Smith H. S., Painful osseous metastases. Pain Physician 2011 14 4 E373 E405 2-s2.0-79960871485
4. Mercadante S., Malignant bone pain: pathophysiology and treatment. Pain 1997 69 1-2 1 18 2-s2.0-0031056437 10.1016/S0304-3959(96)03267-8 (Pubitemid 27081402)
5. Mercadante S., Managing breakthrough pain. Current Pain and Headache Reports 2011 15 4 244 249 2-s2.0-79952707013 10.1007/s11916-011-0191-5
6. Lawlor P. G., Bruera E., Side-effects of opioids in chronic pain treatment. Current Opinion in Anaesthesiology 1998 11 5 539 545 2-s2.0-0031731399 10.1097/00001503-199810000-00016 (Pubitemid 28484499)
7. Honore P., Rogers S. D., Schwei M. J., Salak-Johnson J. L., Luger N. M., Sabino M. C., Clohisy D. R., Mantyh P. W., Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000 98 3 585 598 2-s2.0-0034130227 10.1016/S0306-4522(00)00110-X (Pubitemid 30408178)
8. Peters C. M., Ghilardi J. R., Keyser C. P., Kubota K., Lindsay T. H., Luger N. M., Mach D. B., Schwei M. J., Sevcik M. A., Mantyh P. W., Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Experimental Neurology 2005 193 1 85 100 2-s2.0-20144387562 10.1016/j.expneurol. 2004.11.028 (Pubitemid 40463270)
9. Schwei M. J., Honore P., Rogers S. D., Salak-Johnson J. L., Finke M. P., Ramnaraine M. L., Clohisy D. R., Mantyh P. W., Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. Journal of Neuroscience 1999 19 24 10886 10897 2-s2.0-0033573528 (Pubitemid 30235733)
10. Pacharinsak C., Beitz A., Animal models of cancer pain. Comparative Medicine 2008 58 3 220 233 2-s2.0-46849095396 (Pubitemid 351954728)
11. Sevcik M. A., Ghilardi J. R., Peters C. M., Lindsay T. H., Halvorson K. G., Jonas B. M., Kubota K., Kuskowski M. A., Boustany L., Shelton D. L., Mantyh P. W., Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 2005 115 1-2 128 141 2-s2.0-20144388553 10.1016/j.pain.2005.02.022
12. Geis C., Graulich M., Wissmann A., Hagenacker T., Thomale J., Sommer C., Schäfers M., Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience 2010 169 1 463 474 2-s2.0-77953809027 10.1016/j.neuroscience.2010. 04.022
13. Sevcik M. A., Ghilardi J. R., Halvorson K. G., Lindsay T. H., Kubota K., Mantyh P. W., Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model. Journal of Pain 2005 6 11 771 775 2-s2.0-27644540532 10.1016/j.jpain.2005.06.010 (Pubitemid 41579075)
14. Sabino M. A. C., Ghilardi J. R., Jongen J. L. M., Keyser C. P., Luger N. M., Mach D. B., Peters C. M., Rogers S. D., Schwei M. J., De Felipe C., Mantyh P. W., Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Research 2002 62 24 7343 7349 2-s2.0-0037115425 (Pubitemid 36025258)
15. Collier H. O. J., James G. W. L., Schneider C., Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5′-triphosphate. Nature 1966 212 5060 411 412 2-s2.0-0014025239 10.1038/212411a0
16. Burnstock G., Purinergic receptors and pain. Current Pharmaceutical Design 2009 15 15 1717 1735 2-s2.0-67650590969 10.2174/138161209788186335
17. Burnstock G., A unifying purinergic hypothesis for the initiation of pain. The Lancet 1996 347 9015 1604 1605 2-s2.0-0029892771 10.1016/S0140- 6736(96)91082-X (Pubitemid 26170881)
18. Tsuda M., Tozaki-Saitoh H., Inoue K., Pain and purinergic signaling. Brain Research Reviews 2010 63 1-2 222 232 2-s2.0-77949778470 10.1016/j.brainresrev.2009.11.003
19. Vial C., Roberts J. A., Evans R. J., Molecular properties of ATP-gated P2X receptor ion channels. Trends in Pharmacological Sciences 2004 25 9 487 493 2-s2.0-4344701877 10.1016/j.tips.2004.07.008 (Pubitemid 39149705)
20. Hattori M., Gouaux E., Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 2012 485 207 212 10.1038/nature11010
21. 4 ion channel in the closed state. Nature 2009 460 7255 592 598 2-s2.0-67949117176 10.1038/nature08198
22. Browne L. E., Jiang L. H., North R. A., New structure enlivens interest in P2X receptors. Trends in Pharmacological Sciences 2010 31 5 229 237 2-s2.0-77952551628 10.1016/j.tips.2010.02.004
23. North R. A., Molecular physiology of P2X receptors. Physiological Reviews 2002 82 4 1013 1067 2-s2.0-0036788971
24. 7. Cloning and expression of a human cDNA. The Journal of Biological Chemistry 1997 272 9 5482 5486 2-s2.0-0031052095 10.1074/jbc.272.9.5482 (Pubitemid 27102368)
25. 7-Like properties. The Journal of Neuroscience 2012 32 12 4284 4296
26. 4 receptor channels form large noncytolytic pores in resting and activated microglia. Glia 2012 60 5 728 737 10.1002/glia.22301
27. Burnstock G., Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Bioessays 2012 34 3 218 225 10.1002/bies.201100130
28. Felix R. A., Martin S., Pinion S., Crawford D. J., Development of a comprehensive set of P2 receptor pharmacological research compounds. Purinergic Signalling 2012 8 supplement 1 101 112
29. Lambrecht G., Friebe T., Grimm U., Windscheif U., Bungardt E., Hildebrandt C., Baumert H. G., Spatz-Kumbel G., Mutschler E., PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. European Journal of Pharmacology 1992 217 2-3 217 219 2-s2.0-0026684355 10.1016/0014-2999(92)90877-7
30. 3 receptor involvement in pain states. Molecular Neurobiology 2007 36 2 165 183 2-s2.0-38449111937 10.1007/s12035-007-0033-y (Pubitemid 351360342)
31. Julius D., Basbaum A. I., Molecular mechanisms of nociception. Nature 2001 413 6852 203 210 2-s2.0-0035855860 10.1038/35093019 (Pubitemid 32867885)
32. Djouhri L., Lawson S. N., A β -fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent a-fiber neurons in mammals. Brain Research Reviews 2004 46 2 131 145 2-s2.0-16644365574 10.1016/j.brainresrev.2004.07.015 (Pubitemid 39298861)
33. Doubell T. P., Mannion R. J., Woolf C. J., Wall P. D., Melzack R., The dorsal horn: State-dependent sensory processing, plasticity and the generation of pain. Textbook of Pain 1999 4th
34. 3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology 1997 36 9 1229 1242 2-s2.0-0030609075 10.1016/S0028-3908(97)00126-3 (Pubitemid 27465611)
35. Dunn P. M., Zhong Y., Burnstock G., P2X receptors in peripheral neurons. Progress in Neurobiology 2001 65 2 107 134 2-s2.0-0034983559 10.1016/S0301-0082(01)00005-3 (Pubitemid 32524181)
36. 3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal 2012 8 supplement 1 3 26 10.1007/s11302-011-9271-6
37. 3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Molecular and Cellular Neurosciences 1998 12 4-5 256 268 2-s2.0-0031593393 10.1006/mcne.1998.0719 (Pubitemid 28536078)
38. 3 is expressed by DRG neurons that terminate in inner lamina II. European Journal of Neuroscience 1998 10 11 3470 3478 2-s2.0-0032217032 10.1046/j.1460-9568.1998. 00355.x (Pubitemid 29074138)
39. Novakovic S. D., Kassotakis L. C., Oglesby I. B., Smith J. A. M., Eglen R. M., Ford A. P. D. W., Hunter J. C., Immunocytochemical localization of P 2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 1999 80 1-2 273 282 2-s2.0-0032588156 10.1016/S0304-3959(98)00225-5 (Pubitemid 29151712)
40. Xu G. Y., Huang L. Y. M., Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. Journal of Neuroscience 2002 22 1 93 102 2-s2.0-0036139259
41. 3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Brain Research 2005 1044 2 197 205 2-s2.0-18844449876 10.1016/j.brainres.2005.02.081 (Pubitemid 40693452)
42. Nagamine K., Ozaki N., Shinoda M., Asai H., Nishiguchi H., Mitsudo K., Tohnai I., Ueda M., Sugiura Y., Mechanical allodynia and thermal hyperalgesia induced by experimental squamous cell carcinoma of the lower gingiva in rats. Journal of Pain 2006 7 9 659 670 2-s2.0-33747873540 10.1016/j.jpain.2006.02.013 (Pubitemid 44291602)
43. Xiang Z., Bo X., Burnstock G., Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neuroscience Letters 1998 256 2 105 108 2-s2.0-0032491542 10.1016/S0304-3940(98)00774-5 (Pubitemid 28529708)
44. Barden J. A., Bennett M. R., Distribution of P2X purinoceptor clusters on individual rat dorsal root ganglion cells. Neuroscience Letters 2000 287 3 183 186 2-s2.0-0034734033 10.1016/S0304-3940(00)01150-2 (Pubitemid 30339379)
45. Ruan H. Z., Burnstock G., Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochemistry and Cell Biology 2003 120 5 415 426 2-s2.0-0346846752 10.1007/s00418-003-0579-3 (Pubitemid 38005361)
46. Aoyama R., Okada Y., Yokota S., Yasui Y., Fukuda K., Shinozaki Y., Yoshida H., Nakamura M., Chiba K., Yasui Y., Kato F., Toyama Y., Spatiotemporal and anatomical analyses of P2X receptor-mediated neuronal and glial processing of sensory signals in the rat dorsal horn. Pain 2011 152 9 2085 2097 2-s2.0-79958048293 10.1016/j.pain.2011.05.014
47. 2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. Journal of Comparative Neurology 1999 407 1 11 32 2-s2.0-0033611826 (Pubitemid 29161990)
48. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003 424 6950 778 783 2-s2.0-0042968804 10.1038/nature01786 (Pubitemid 37021707)
49. 4 receptors and p38 MAPK in microglia. Glia 2009 57 6 583 591 2-s2.0-65549155435 10.1002/glia.20786
50. 7 receptor-mediated release of excitatory amino acids from astrocytes. Journal of Neuroscience 2003 23 4 1320 1328 2-s2.0-0037440567 (Pubitemid 36258910)
51. Kukley M., Barden J. A., Steinhäuser C., Jabs R., Distribution of P2x receptors on astrocytes in juvenile rat hippocampus. Glia 2001 36 1 11 21
52. 7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. Journal of Neuroscience 2001 21 18 7135 7142 2-s2.0-0035884937 (Pubitemid 32846961)
53. 2+ signaling. Journal of Neuroscience 2006 26 5 1378 1385 2-s2.0-32544448639 10.1523/JNEUROSCI.3902-05.2006 (Pubitemid 43237008)
54. 7-dependent release of interleukin-1 β and nociception in the spinal cord following lipopolysaccharide. Journal of Neuroscience 2010 30 2 573 582 2-s2.0-74949123761 10.1523/JNEUROSCI.3295-09.2010
55. 7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain, Behavior, and Immunity 2010 24 7 1176 1189 2-s2.0-77954113789 10.1016/j.bbi.2010.06.001
56. Mach D. B., Rogers S. D., Sabino M. C., Luger N. M., Schwei M. J., Pomonis J. D., Keyser C. P., Clohisy D. R., Adams D. J., O'Leary P., Mantyh P. W., Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur. Neuroscience 2002 113 1 155 166 2-s2.0-0037008424 10.1016/S0306-4522(02) 00165-3 (Pubitemid 34786021)
57. Serre C. M., Farlay D., Delmas P. D., Chenu C., Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 1999 25 6 623 629 2-s2.0-0032696046 10.1016/S8756-3282(99)00215-X (Pubitemid 29525427)
58. Jimenez-Andrade J. M., Mantyh W. G., Bloom A. P., Xu H., Ferng A. S., Dussor G., Vanderah T. W., Mantyh P. W., A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain. Bone 2010 46 2 306 313 2-s2.0-74249114795 10.1016/j.bone.2009.09.013
59. Ivanusic J. J., Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia. Journal of Comparative Neurology 2009 517 3 276 283 2-s2.0-70349840645 10.1002/cne.22160
60. Orriss I. R., Burnstock G., Arnett T. R., Purinergic signalling and bone remodelling. Current Opinion in Pharmacology 2010 10 3 322 330 2-s2.0-77954660043 10.1016/j.coph.2010.01.003
61. Morrison M. S., Turin L., King B. F., Burnstock G., Arnett T. R., ATP is a potent stimulator of the activation and formation of rodent osteoclasts. Journal of Physiology 1998 511 2 495 500 2-s2.0-0003982630 10.1111/j.1469-7793. 1998.495bh.x (Pubitemid 28444617)
62. 2 purinoceptor to ATP revealed by changing extracellular pH. British Journal of Pharmacology 1996 117 7 1371 1373 2-s2.0-0029666411
63. Hoebertz A., Townsend-Nicholson A., Glass R., Burnstock G., Arnett T. R., Expression of P2 receptors in bone and cultured bone cells. Bone 2000 27 4 503 510 2-s2.0-0033805063 10.1016/S8756-3282(00)00351-3
64. Orriss I., Syberg S., Wang N., Bone phenotypes of P2 receptor knockout mice. Frontiers in Bioscience 2011 3 1038 1046
65. Hald A., Hansen R. R., Thomsen M. W., Ding M., Croucher P. I., Gallagher O., Ebetino F. H., Kassem M., Heegaard A. M., Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. International Journal of Cancer 2009 125 5 1177 1185 2-s2.0-67650070530 10.1002/ijc.24436
66. Mantyh W. G., Jimenez-Andrade J. M., Stake J. I., Bloom A. P., Kaczmarska M. J., Taylor R. N., Freeman K. T., Ghilardi J. R., Kuskowski M. A., Mantyh P. W., Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 2010 171 2 588 598 2-s2.0-78149280765 10.1016/j.neuroscience.2010.08.056
67. 2/3 receptors attenuates bone cancer pain behaviour in rats. Brain 2010 133 9 2549 2564 2-s2.0-77956389019 10.1093/brain/awq194
68. 3 receptors. Neuroscience Letters 2009 465 3 285 289 2-s2.0-70349783550 10.1016/j.neulet. 2009.09.015
69. 2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice. European Journal of Pharmacology 2012 688 13 27 34
70. 3 receptors in dorsal root ganglion in a rat model of bone cancer pain. European Journal of Pain. In press 10.1002/j.1532-2149.2012.00149.x
71. 3 expression in sensory neurons. Journal of Neurochemistry 2001 77 3 864 875 2-s2.0-0035010365 10.1046/j.1471-4159.2001.00288.x (Pubitemid 32466783)
72. Jarvis M. F., The neural-glial purinergic receptor ensemble in chronic pain states. Trends in Neurosciences 2010 33 1 48 57 2-s2.0-73449108381 10.1016/j.tins.2009.10.003
73. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 17179 17184 2-s2.0-0037168683 10.1073/pnas.252537299 (Pubitemid 36034118)
74. 2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. British Journal of Pharmacology 2005 146 2 180 188 2-s2.0-30544443440 10.1038/sj.bjp.0706346 (Pubitemid 43079957)
75. Ji R. R., Gereau R. W., Malcangio M., Strichartz G. R., MAP kinase and pain. Brain Research Reviews 2009 60 1 135 148
76. 4 purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts. Journal of Cell Science 1999 112 23 4425 4435 2-s2.0-0033491119 (Pubitemid 30122034)
77. Woolf C. J., Salter M. W., Neuronal plasticity: increasing the gain in pain. Science 2000 288 5472 1765 1768 2-s2.0-0034625770 10.1126/science.288. 5472.1765 (Pubitemid 30399008)
78. Honore P., Luger N. M., Sabino M. A. C., Schwei M. J., Rogers S. D., Mach D. B., O'Keefe P. F., Ramnaraine M. L., Clohisy D. R., Mantyh P. W., Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nature Medicine 2000 6 5 521 528 2-s2.0-0034105966 10.1038/74999 (Pubitemid 30305901)
79. Hald A., Nedergaard S., Hansen R. R., Ding M., Heegaard A. M., Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. European Journal of Pain 2009 13 2 138 145 2-s2.0-58149347812 10.1016/j.ejpain.2008.03.014
80. Illes P., Verkhratsky A., Burnstock G., Franke H., P2X receptors and their roles in astroglia in the central and peripheral nervous system. The Neuroscientist. In press 10.1177/1073858411418524
81. Fields R. D., Burnstock G., Purinergic signalling in neuron-glia interactions. Nature Reviews Neuroscience 2006 7 6 423 436 2-s2.0-33745738972 10.1038/nrn1928 (Pubitemid 44012283)
82. 4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. Journal of Neuroscience 2008 28 44 11263 11268 2-s2.0-56149096976 10.1523/JNEUROSCI.2308-08.2008
83. 4-receptor- mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. Journal of Neuroscience 2009 29 11 3518 3528 2-s2.0-63849192564 10.1523/JNEUROSCI.5714-08.2009
84. Coull J. A. M., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M. W., De Koninck Y., BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005 438 7070 1017 1021 2-s2.0-30744439794 10.1038/nature04223 (Pubitemid 43093974)
85. 7 receptor: a key player in IL-1 processing and release. Journal of Immunology 2006 176 7 3877 3883 2-s2.0-33646072818 (Pubitemid 44264361)
86. Hide I., Tanaka M., Inoue A., Nakajima K., Kohsaka S., Inoue K., Nakata Y., Extracellular ATP triggers tumor necrosis factor- α release from rat microglia. Journal of Neurochemistry 2000 75 3 965 972 2-s2.0-0033836116 10.1046/j.1471-4159.2000.0750965.x (Pubitemid 30660484)
87. 7 receptor-activated microglia. Journal of Neuroscience 2004 24 1 1 7 2-s2.0-0842322759 10.1523/JNEUROSCI.3792-03.2004 (Pubitemid 38181664)
88. Inoue K., P2 receptors and chronic pain. Purinergic Signalling 2007 3 1-2 135 144 2-s2.0-33947629663 10.1007/s11302-006-9045-8
89. Bianco F., Pravettoni E., Colombo A., Schenk U., Möller T., Matteoli M., Verderio C., Astrocyte-derived ATP induces vesicle shedding and IL-1 β release from microglia. Journal of Immunology 2005 174 11 7268 7277 2-s2.0-18944380607 (Pubitemid 40705696)
90. Montana V., Malarkey E. B., Verderio C., Matteoli M., Parpura V., Vesicular transmitter release from astrocytes. Glia 2006 54 7 700 715 2-s2.0-33750327152 10.1002/glia.20367 (Pubitemid 44629633)
91. Stout C. E., Costantin J. L., Naus C. C. G., Charles A. C., Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. The Journal of Biological Chemistry 2002 277 12 10482 10488 2-s2.0-0037155841 10.1074/jbc.M109902200 (Pubitemid 34968170)
92. Li S., Bjelobaba I., Yan Z., Kucka M., Tomić M., Stojilkovic S. S., Expression and roles of pannexins in ATP release in the pituitary gland. Endocrinology 2011 152 6 2342 2352 2-s2.0-79956336722 10.1210/en.2010-1216
93. 7 receptors: properties and relevance to CNS function. Glia 2006 54 7 738 746 2-s2.0-33750327150 10.1002/glia.20397 (Pubitemid 44629636)
94. Sung B., Lim G., Mao J., Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. Journal of Neuroscience 2003 23 7 2899 2910 2-s2.0-0037390214 (Pubitemid 36418626)
95. Wang W., Wang W., Wang Y., Huang J., Wu S., Li Y. Q., Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain. Anatomical Record 2008 291 5 513 518 2-s2.0-43149108624 10.1002/ar.20673 (Pubitemid 351644525)
96. Xin W. J., Weng H. R., Dougherty P. M., Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Molecular Pain 2009 5, article 15 2-s2.0-65749105558 10.1186/1744-8069-5-15
97. Tawfik V. L., Regan M. R., Haenggeli C., LaCroix-Fralish M. L., Nutile-McMenemy N., Perez N., Rothstein J. D., DeLeo J. A., Propentofylline- induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 2008 152 4 1086 1092 2-s2.0-41549147179 10.1016/j.neuroscience.2008.01.065
98. 7 receptor-mediated phosphoinositide 3-kinase signaling. Journal of Neurochemistry 2010 113 1 213 227 2-s2.0-77749243037 10.1111/j.1471-4159.2010.06589.x
99. 7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms. Journal of Neurochemistry 2008 105 1 151 164 2-s2.0-41249083804 10.1111/j.1471-4159.2007. 05119.x (Pubitemid 351444678)
100. 7 receptor stimulation in primary cultures of rat spinal microglia induces downregulation of the activity for glutamate transport. Glia 2008 56 5 528 538 2-s2.0-44949230478 10.1002/glia.20634
101. 2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels. Proceedings of the National Academy of Sciences of the United States of America 2008 105 33 12063 12068 2-s2.0-50149118145 10.1073/pnas.0803008105
102. 7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization. Journal of Molecular Neuroscience 2012 46 3 585 594
103. 7 receptor. EMBO Journal 2006 25 21 5071 5082 2-s2.0-33750473352 10.1038/sj.emboj.7601378 (Pubitemid 44658525)
104. 7 receptor death complex. FEBS Letters 2007 581 3 483 488 2-s2.0-33846438625 10.1016/j.febslet.2006.12.056 (Pubitemid 46149626)
105. Egan T. M., Samways D. S. K., Li Z., Biophysics of P2X receptors. Pflugers Archiv European Journal of Physiology 2006 452 5 501 512 2-s2.0-33745753599 10.1007/s00424-006-0078-1 (Pubitemid 44015087)
106. 7 receptor pore. British Journal of Pharmacology 2011 163 5 908 911 2-s2.0-79958789017 10.1111/j.1476-5381.2011.01325.x
107. 7 receptor-expressing cells: implications for its therapeutic action. British Journal of Pharmacology 2011 163 5 912 926 2-s2.0-79958836059 10.1111/j.1476-5381.2011.01254.x
108. 7 receptor reveal differential agonist-dependence and functional coupling with pannexin-1. Journal of Cell Science. In press
109. 7 receptor and human disease. Purinergic Signalling 2009 5 2 257 262 2-s2.0-67349124829 10.1007/s11302-009-9136-4
110. 7 receptor-deficient mice. International Journal for Parasitology 2011 41 3 301 308 2-s2.0-79951813574 10.1016/j.ijpara.2010.10.001
111. 7 receptor pore formation regulates variability in chronic pain sensitivity. Nature Medicine 2012 18 4 595 599 10.1038/nm.2710
112. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005 114 3 386 396 2-s2.0-20144375454 10.1016/j.pain.2005.01.002 (Pubitemid 40385877)
113. 7 receptor-deficient mice are susceptible to bone cancer pain. Pain 2011 152 8 1766 1776 2-s2.0-79960453380 10.1016/j.pain.2011. 03.024
114. Yao M., Chang X., Chu Y., Yang J., Wang L., Cao H., Liu M., Xu Q., Antiallodynic effects of propentofylline elicited by interrupting spinal glial function in a rat model of bone cancer pain. Journal of Neuroscience Research 2011 89 11 1877 1886 2-s2.0-79960894401 10.1002/jnr.22711
115. Wang L. N., Yang J. P., Zhan Y., Minocycline-induced reduction of brain-derived neurotrophic factor expression in relation to cancer-induced bone pain in rats. Journal of Neuroscience Research 2012 90 3 672 681 10.1002/jnr.22788
116. 7 knock-out mice. The Journal of Biological Chemistry 2009 284 38 25813 25822 2-s2.0-70350012258 10.1074/jbc.M109.033134
117. Kobayashi K., Yamanaka H., Fukuoka T., Dai Y., Obata K., Noguchi K., P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. Journal of Neuroscience 2008 28 11 2892 2902 2-s2.0-40849089273 10.1523/JNEUROSCI.5589-07.2008 (Pubitemid 351398864)
118. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., Inoue K., P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. Journal of Neuroscience 2008 28 19 4949 4956 2-s2.0-44949147139 10.1523/JNEUROSCI.0323-08.2008
119. Xiao H. S., Huang Q. H., Zhang F. X., Bao L., Lu Y. J., Guo C., Yang L., Huang W. J., Fu G., Xu S. H., Cheng X. P., Yan Q., Zhu Z. D., Zhang X., Chen Z., Han Z. G., Zhang X., Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America 2002 99 12 8360 8365 2-s2.0-0037062494 10.1073/pnas.122231899 (Pubitemid 34651057)
120. Chen J., Wang L., ZhangYang J. Y., Yang J., P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain. Acta Biochimica et Biophysica Sinica 2012 44 4 367 372 10.1093/abbs/gms007
121. Burnstock G., Physiology and pathophysiology of purinergic neurotransmission. Physiological Reviews 2007 87 2 659 797 2-s2.0-34248576759 10.1152/physrev.00043.2006 (Pubitemid 47084682)
122. 3 receptor-channels in rat dorsal root ganglion neurons. European Journal of Pharmacology 2005 521 13 34 38 2-s2.0-26444575422 10.1016/j.ejphar.2005.08.001 (Pubitemid 41427787)